POSTMENOPAUSAL ENDOMETRIUM
description
Transcript of POSTMENOPAUSAL ENDOMETRIUM
![Page 1: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/1.jpg)
POSTMENOPAUSAL ENDOMETRIUM
Dr. Sharda JainDirector: Global Institute of Gynaecoloy at Pushpanjali
Crosslay HospitalSecretary general: Delhi
Gynaecologist Forum
![Page 2: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/2.jpg)
Learning objectives• Menopause • Normal Postmenopausal Endometrium • Pathophysiology: before & after menopause • What warrants investigations • Case Studies• Endomtrial evaluation • Personal Experience• Review of Literature
![Page 3: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/3.jpg)
•AFTER 12 MONTHS' SPONTANEOUS AMENORRHOEA.
•FSH >30
Menopause
![Page 4: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/4.jpg)
Postmenopausal Endometrium
No more than thin line
2.3 mm ± 1.8 mm(0-10)
![Page 5: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/5.jpg)
PRIOR TO MENOPAUSE:• Short cycle (↓ proliferative)
• ↑ Moderate Elevation of FSH
• Anovulation – Unapposed oest
- DUB
- Hyperplastic endo.
PATHOPHYSIOLOGY
![Page 6: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/6.jpg)
PATHOPHYSIOLOGYOnce menopause occurs, oestrogen and progesterone are no longer produced by the ovaries; nor are they produced in any appreciable amounts by the liver and fat.
The endometrium regresses to some degree, and no further bleeding should occur.
If bleeding does resume - endometrium must be evaluated.
![Page 7: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/7.jpg)
AMENORRHEIC + NO HORMONE THERAPY 4.0SEQUENTIAL HORMONE THERAPY (DAY 5) 4.0ESTROGEN ALONE/COMBINED ESTROGEN 5.5WITH PROGESTERONETIBOLONE 5.5RALOXIFENE 4.0
TAMOXIFEN 8.0
HYPERTENSIVE ON MEDICATION 6.5
Norms for Endometrial Thickness inPostmenopausal Women (MM)
![Page 8: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/8.jpg)
WHAT WARRANTS
INVESTIGATION
AND EVALUATION?
![Page 9: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/9.jpg)
Fluid - Anachoic area ↑ Endometrium – Warrants investigation
Thick Endometrium
NO POST MENOPAUSAL BLEEDING
![Page 10: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/10.jpg)
POST MENOPAUSAL BLEEDING
• PRECANCEROUS / CANCER of cervix & uterus• Benign conditions – eg. Polyp
• Chronic endometritis- eg. TB• Disorders of coagulation/ Blood dyscrasias
• Systemic Disease- eg. Hypertension • Drugs – anticoagulants, Tamoxiphen.
Herbal drugs, HRT
![Page 11: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/11.jpg)
Postmenopausal Bleeding
• Benign conditions are most frequent causes of PMB but endometrial cancer is the most serious potential underlying cause
• One Should think endo. Ca untill proven otherwise.
![Page 12: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/12.jpg)
75% of women with endometrial cancer
are postmenopausal.
RISK ASSESSMENT
![Page 13: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/13.jpg)
RISK FACTORS FOR ENDOMETRIAL CANCER
are conditions typically associated with chronic elevations of endogenous estrogen levels or increased estrogen action at the level of the endometrium. These include
OBESITY. HISTORY OF CHRONIC ANOVULATION. DIABETES MELLITUS. ESTROGEN-SECRETING TUMORS. EXOGENOUS ESTROGEN UNOPPOSED BY PROGESTERONE . TAMOXIFEN USE. A FAMILY HISTORY OF LYNCH TYPE II SYNDROME
(HEREDITARY NONPOLYPOSIS COLORECTAL, OVARIAN, OR ENDOMETRIAL CANCER).
![Page 14: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/14.jpg)
Systemic conditionsAbnormalities of the hematologic system
also must be considered as a possible cause of postmenopausal bleeding.
On rare occasions, AUB will be the first sign of leukemia or a blood dyscrasia.
Overuse of anticoagulant medications such as aspirin, heparin, and warfarin-which are taken with greater frequency by patients in this age group-may contribute to postmenopausal bleeding.
![Page 15: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/15.jpg)
POSTMENOPAUSAL BLEEDING &
HRT • The occurrence of uterine bleeding or
spotting after the initiation of HRT is not unusual. More than half of HRT users will have some spotting or bleeding at the beginning of therapy.
• Usually such bleeding is lighter than a menstrual period and lessens with time; after 6 months, it stops completely in most women.
![Page 16: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/16.jpg)
ENDOMETRIAL EVALUATION IS CALLED FOR WHEN :
1. any menopausal woman not taking HRT develops uterine bleeding after more than 1 year of amenorrhea.
2. any postmenopausal woman on HRT for 6 months or more with persistent uterine bleeding.
3. and any previously amenorrheic woman on HRT who begins bleeding without apparent cause.
![Page 17: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/17.jpg)
CASE STUDY - 164 years old G2 P2 : 16 years postmenopausal
• Went to physician for pain in abdomen• Ultrasound revealed18 mm endometrial strip• No discharge/ No Bleeding, 70 kg, BMI - 32• Mild hypert, DM controlled.
• EB – Well differentiated Adeno Carcinoma • Staging laparotmy and pan hysterectomy
• IA- Disease
![Page 18: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/18.jpg)
68 years• Menopausal 20 years• 3 episodes of bleeding in last 6 weeks• Hypertension/ diabetic/ obese/ BMI-31• TVS – Uterus bulky for age. Endometrial strip is 18
mm. • Office E.B. well differentiated adeno-carcinoma• 1 A disease
CASE STUDY-2
![Page 19: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/19.jpg)
54 years, professor in DU
• Menopause = 48 years
• Single episode of spotting on 13/8/2010
• TVS – 7-8 mm
• HPE – Clear all Endo. Ca.
CASE STUDY - 3
![Page 20: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/20.jpg)
CASE STUDY - 4• 54 year old G2 P2• Had HRT at age 50 for Hot flushes – 6 months• Presented with 3 episodes of vaginal bleeding over last 6 weeks (3 years after
menopause)• TVS show endometrial strip of 12 mm, Uterus- normal in size.
• E.B. proliferative endometrium• Hysteroscopy normal …. Spotting for 3 months
• Refused Hysterectomy
Uterine Balloon Therapy
![Page 21: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/21.jpg)
60 YEARS, UNMARRIED PROFESSOR• Menopause – 48 years
• 52 years – Heavy Bleeding
• Ultrasound – 3-4 mm Endo. Strip
• D&C /Hysterectomy – Simple hyperplasia
of endometrium
- Refused Hysterectomy
Uterine Balloon Therapy
CASE STUDY - 5
![Page 22: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/22.jpg)
CASE STUDY-656 years multi gravida Pain in lower abdomen + ; No Postmenopausal Bleeding • Appears well• BMI < 25, 60 kg• Normotensive• General exam unremarkable• Speculum: CERVICAL POLYP• Ultrasound - Uterus normal, endometrium 12 mm, Both
ovaries normal• INFLAMMATORY POLYP AND TUBERCULAR
ENDOMETRITIS
ATT Given - EB &- Hysteroscopy
![Page 23: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/23.jpg)
THE DURATION OR AMOUNT (STAINING VS GROSS) OF BLEEDING DOES NOT MAKE ANY DIFFERENCE.
IT GIVES NO CLUE TO DIAG.
SAME IS TRUE FOR ENDOMETRIAL THICKNESS.
RISK ASSESSMENT
![Page 24: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/24.jpg)
• Vaginal ultrasonography.
• Saline infusion sonography (Hydrosonography)
• Office Endometrial biopsy.
• Conventional F/C or D/C
• Hysteroscopic guided biopsy.
DIAGNOSTIC TOOLS
![Page 25: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/25.jpg)
Sensitivity and specificity are often used to summarise the performance of a diagnostic test.
Sensitivity is the probability of testing positive if the disease is truly present.
Specificity is the probability of testing negative if the disease is truly absent.
![Page 26: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/26.jpg)
VAGINAL ULTRASOUND
![Page 27: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/27.jpg)
Although the test is very specific , it isn't sensitive. Many women without endometrial cancer will have an endometrial thickness of 4 mm or more
VAGINAL ULTRASOUND
![Page 28: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/28.jpg)
A CUT-OFF THRESHOLD OF 3 MM
OR 5MM ?cut-off point of 3 mm is less likely to
miss cancer than cut-offs of 5 mm.
But unfortunately a lower cut-off means a greater proportion of women requiring invasive investigation.
![Page 29: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/29.jpg)
THE PATIENT RISK GROUP
•Low pre-test probability•On HRT•On tamoxifen therapy
• High pre-test Probability (high risk)
Cut off threshold 5mm Cut off threshold 3mm
![Page 30: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/30.jpg)
Endometrial polyp in hyperechoic thickened endometrium
![Page 31: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/31.jpg)
![Page 32: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/32.jpg)
The introduction of intrauterine fluid (saline-infusion sonography) during transvaginal ultrasound is one of the most significant advances in ultrasonography of the past decade.
SALINE – INFUSION SONOGRAPHY
![Page 33: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/33.jpg)
Uterine fibroids and adenomyomas generally are apparent on ultrasound. Uterine polyps may appear as a thickened endometrial stripe, but these and submucous myomas can be clearly identified as filling defects when a SIS is performed
SALINE – INFUSION SONOGRAPHY (SIS)
![Page 34: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/34.jpg)
At transvaginal ultrasonography , the finding of a thickened central endometrial complex, with or without cystic changes, is often
nonspecific.
![Page 35: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/35.jpg)
The Thickened endometrium may be a polyp
With polyps the endometrial-myometrialinterface is preserved
CYST
POLYP
well-defined, homogeneous,isoechoic to the endometrium
![Page 36: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/36.jpg)
The Thickened endometrium
may be a polyp
With polyps the endometrial-myometrialinterface is preserved
POLYPcatheter
![Page 37: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/37.jpg)
• Office Endometrial Biopsy
![Page 38: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/38.jpg)
A useful suction endomtrial sampling (Probet) with 3.1 mm in outside diameter and no pump or syringe
required.
![Page 39: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/39.jpg)
An endometrial suction sampling with syringe vacuum
![Page 40: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/40.jpg)
SAMPLING OF THE ENDOMETRIUM
• OFFICE BIOPSY PROCEDURE (Probet Endometrial Curette, Vabra aspirator, Karman cannula) will agree with a D&C under GA ~95% of the time
• Office biopsy has a 16% false negative rate when the lesion is a polyp or the cancer covering less than 5% of the endometrium– Guido et al. J Reprod Med. 1995;40:553
![Page 41: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/41.jpg)
Preoperative D&C will agree with diagnosis at hysterectomy - 95% of the time
The role today of the formal D&C or F/C probably is very limited because the diagnosis usually can be made in the office by endometrial biopsy (95%).
DILATATION AND CURETTAGE
“Gold STANDARD”
![Page 42: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/42.jpg)
Hysteroscopic visualization has several advantages:
immediate office evaluation, visualization of the endometrium and
endocervix, the ability to detect minute focal
endometrial pathology and to perform directed endometrial biopsies.
OFFICE HYSTEROSCOPIC-DIRECTED BIOPSY
![Page 43: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/43.jpg)
ACOG/ CANADIAN (SOGC) WHAT TO DO?
CLINICAL PRACTICE GUIDELINES
2000• Endometrium ≥ 4, even if No bleeding
• Abnormal vaginal bleeding after menopause
↓• Endometrial Cancer must be ruled out
![Page 44: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/44.jpg)
A SYSTEMATIC REVIEW OF 90 STUDIES AND META-
ANALYSIS
ENDOMETRIAL THICKNESS MEASUREMENT FOR DETECTING
ENDOMETRIAL CANCER IN WOMENWITH POSTMENOPAUSAL
BLEEDINg: Opmeer BC, Khan KS et.al (Obstet Gyneol 2010;116:160-7)
![Page 45: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/45.jpg)
Meta analysis 90 Studies of POST MENOPAUSAL BLEEDING
• OVERESTIMATED THE DIAGNOSTIC ACCURACY OF ENDOMETRIUM THICKNESS
• CRITICAL THICKNESS – 3 MM TO R/O ENDOMETRIAL CARCINOMA
Opmeer & KanObsted Gynee 2020
![Page 46: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/46.jpg)
CRITICAL THICKNESS – 3 mm
•unexplained
![Page 47: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/47.jpg)
No Bleeding TVS
Endometrial
thickness is > 3mm
If low risk
office endometrialbiopsy and SIS
If high risk
D/C biopsy ORHysteroscopy
Or both
fail to do If
Endometrialthickness is < 3mm
follow
But symptoms persist
IN WOMEN WITH CONTINUED BLEEDING AFTER A NEGATIVE INITIAL EVALUATION, FURTHER TESTING
WITH HYSTEROSCOPICALLY DIRECTED BIOPSY IS ESSENTIAL,
![Page 48: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/48.jpg)
Unsatisfactory, unable to do
Low Risk for Ca High Risk for Ca D&C (D&C + hysteroscopy) ± Hysteroscopy
Post Menopausal Bleeding TVS
Office Endometrial Biopsy
![Page 49: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/49.jpg)
POST MENOPAUSAL BLEEDING (Our Experience)
Etiology %
Atrophic Endometrium 31
Endo. Hyperplasia (simple complex, atypical)
26
Endometrial Ca. 14
Polyp endo/ cervical 6
Proliferative Endo (Exogenous Estrogen)
1
Total (Jan 2007 – till date) 78
![Page 50: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/50.jpg)
Post Menopausal Endometrium
Endometrium (mm)
Number of Patient
Details
<5 32 Atrophic-31, Cancer-1
<10 16 Cervical Polyp- 3, Endo. Polyp-3, Cancer – 1, Simple Hyperplasia-9,
>10 30 Carcinoma- = 12 Submucous fibroid-1, Simple hyperplasia - 14 Complex hyperplasia-2 Atypical = 1
Total 78
![Page 51: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/51.jpg)
NORMAL ENDOMETRIUM
![Page 52: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/52.jpg)
ENDOMETRIAL POLYP
![Page 53: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/53.jpg)
POLYP AND ATYPICAL HYPERPLASIA
![Page 54: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/54.jpg)
ENDOMETRIAL CANCER:TRANSVAGINAL ULTRASOUND SCREENING
< 5 mm Endo strip also showed CA.
![Page 55: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/55.jpg)
ENDOMETRIAL CANCER:TRANSVAGINAL ULTRASOUND SCREENING
6 – 10 mm Endo strip also showed CA.
![Page 56: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/56.jpg)
ENDOMETRIAL CANCER:TRANSVAGINAL ULTRASOUND SCREENING
Fluid
![Page 57: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/57.jpg)
Endometrium: Post-menopausal atrophy
![Page 58: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/58.jpg)
ENDOMETRIAL SIMPLE HYPERLASIA
![Page 59: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/59.jpg)
ENDOMETRIAL HYPERLASIA - COMPLEX
![Page 60: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/60.jpg)
ENDOMETRIAL HYPERPLASIA - ATYPICAL
![Page 61: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/61.jpg)
GRADE 1 ENDOMETROID CARCINOMA
![Page 62: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/62.jpg)
GRADE 3 ENDOMETROID CARCINOMA
![Page 63: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/63.jpg)
ENDOMETRIAL CARCINOMA: POOR PROGNOSIS CELL TYPES - PAPILLARY SEROUS
![Page 64: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/64.jpg)
ENDOMETRIAL CARCINOMA - POOR PROGNOSIS CELL TYPES CLEAR CELL
![Page 65: POSTMENOPAUSAL ENDOMETRIUM](https://reader036.fdocuments.in/reader036/viewer/2022062314/56814816550346895db543c0/html5/thumbnails/65.jpg)